Croft-Leominster’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Croft-Leominster’s Portfolio PRTK Stock Details PRTK Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell
2017 Q2	$241K	Sell
2017 Q1	$375K	Buy
2016 Q4	–	Sell
2016 Q3	$188K	Buy